After finding out that the Raleigh company, Donor Referral Services, harvested bone and tissue corpses without properly reporting critera, patients who had spinal surgery implants are upset that they may have received diseased tissue. According to the FDA, the company listed some donors as younger than they were, listed more than one donor who died of cancer as cancer-free, and failed to identify a donor as an intravenous drug user.
Donor bone fragments are frequently used in orthopedic and neurosurgery procedures to stimulate new bone around a repaired joint or vertebrae. Soft tissues taken from cadavers have a wealth of uses. Donor tendons are used to repair torn ligaments, skin grafts are used to repair burns and pressure sores, and cadaver corneas are used for transplants.
This is the second time in the past year that concerns have been raised about the safety of bone and tissue products used in many corrective surgeries.
In the most recent case involving Donor Referral Services, a distributor in July began to recall tissue it had received from the Raleigh company. On Aug. 18, the FDA shut down Donor Referral Services, citing serious deficiencies in its processing, donor screening, and record-keeping. Local hospitals were alerted to the problem. The FDA needs to revisit and tighten their procedures in monitoring bone and tissue collection and processing. (News Observer)